Everbright Medical & Healthcare Fund

Overview

The Everbright Medical & Healthcare Fund, launched by China Everbright Limited on October 17, 2012, is a private equity fund dedicated to the healthcare sector in China. The fund primarily invests in private companies at various stages of development, including biotechnology, pharmaceuticals, medical devices, healthcare services, and healthcare IT. It completed its first-phase fundraising with committed capital of 600 million RMB and has invested in several leading healthcare companies in China. The fund adopts a long-term investment perspective, focusing on companies with high growth potential and core competencies. It aims to invest in top players within their respective sub-segments, emphasizing intrinsic value to ensure appreciation through long-term ownership. The fund maintains a balanced portfolio by investing mainly in growth-stage private companies, while also considering early-stage companies with high growth potential and the restructuring and privatization of state-owned enterprises. Exit strategies include IPOs, trade sales, and other structural options. Stringent risk control measures are implemented, leveraging China Everbright Limited's established risk control system and the team's industry knowledge and operational experience to conduct thorough due diligence and rigorous post-investment management. The fund benefits from China Everbright Limited's strong government, financial, and enterprise networks in China, supporting fundraising, deal sourcing, execution, and post-investment management. The investment team possesses extensive knowledge and experience in the Chinese market, especially in the healthcare sector, with a deep understanding of products, services, technologies, and market trends. They have built an extensive industry network and deep domain expertise, positioning the fund as a preferred partner for entrepreneurs. With both strong domestic resources and international exposure, China Everbright Limited can assist portfolio companies in their domestic and overseas expansion and facilitate international collaborations. The team is actively involved in portfolio companies' strategy, operations, marketing, sales, technology, M&A, and financing, contributing to their success.

Investment Focus

• High growth potential
• Core competencies
• Top players in respective sub-segments
• Intrinsic value focus
• Long-term ownership
• Growth-stage private companies
• Early-stage companies with high growth potential
• Restructuring and privatization of state-owned enterprises
• Exit strategies: IPOs, trade sales, other structural options
• Stringent risk control measures
• Thorough due diligence
• Rigorous post-investment management
• Strong government, financial, and enterprise networks in China
• Extensive industry knowledge and operational experience
• Deep understanding of products, services, technologies, and market trends
• Extensive industry network and domain expertise
• Assistance in domestic and overseas expansion
• Facilitation of international collaborations
• Active involvement in portfolio companies' strategy, operations, marketing, sales, technology, M&A, and financing

Portfolio Companies